跳至主要内容
临床试验/NCT06090591
NCT06090591招募中不适用

Cardiology Research Dubrava: Single Centre, Prospective Registry

University Hospital Dubrava1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,000
试验地点
1
主要终点
freedom from atrial arrhythmias

研究概览

简要总结

Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.

详细描述

Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.

In this long-term follow-up registry we plan to collect data on clinical status, standard laboratory results including lipidogram values, NTproBNP values after specific interventions (in.ex. TAVI implantation, SGLT2inh prescripition), bleeding complications, and every major cardiovascular event, including cardiovascular death and all cause death.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients implanted with CIED, or with VTE, or with ACS or with TAVI -

排除标准

  • non compliance, not undergoing follow-up at this center

结局指标

主要结局

freedom from atrial arrhythmias

时间窗: 10 years

Freedom from atrial arrhythmias after PVI during mid-term folow-up (1 year) and long-term follow-up

Laboratory levels of NTproBNP

时间窗: 10 years

Laboratory levels of NTproBNP in patients with AFib after PVI, in patients with HF prescribed with SGLT2 inhibitors, in patients with ACS after complete revasculariazation, in patients implanted with CIED

cardiovascular death

时间窗: 10 years

death due to cardiovascular etiology during long term follow-up

Time to revascularization

时间窗: 10 years

Time to revascularization during acute coronary syndrome

Bleeding complications

时间窗: 10 years

Bleeding complications during long-term follow-up in patients prescribed with oral anticoagulation and/or antithrombotic therapy

次要结局

未报告次要终点

研究者

发起方
University Hospital Dubrava
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ivan Zeljkovic

M.D., Ph.D., Associate Professor

University Hospital Dubrava

研究点 (1)

Loading locations...

相似试验

Cardiology Research Dubrava Prospective Registry | 临床试验